Editas Medicine, Inc. (0IFK.L) LSE

2.44

+0.1755(+7.77%)

Updated at December 04 06:46PM

Currency In USD

Valuation

Market Cap104.57M
Enterprise Value8.06M
P/E Ratio-0.87
PEG Ratio-0.14
Price/Sales Ratio5.32
Price/Book Ratio10.69
Enterprise/Revenue3.75
Enterprise/EBITDA-0.65

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-6.09
Operating Margin-6.17

Management Effectiveness

Return On Assets-1.12
Return On Equity-2.42

Income Statement

Revenue32.31M
Revenue/Share0.46
Gross Profit32.31M
EBITDA-233.11M
Net Income-237.09M
Diluted EPS-2.88

Balance Sheet

Total Cash165.65M
Total Cash/Share2.11
Total Debt19.65M
Total Debt/Equity4.05
Current Ratio2.77
Book Value Per Share0.23

Price History

52-Week Change24.23
52-Week High11.79
52-Week Low2.34
Moving Average 50 Days8.49
Moving Average 200 Days8.69

Statistics

Average Volume5,909
Shares Outstanding85.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A